Scientists at Harvard Medical School and Boston University Chobanian & Avedisian School of Medicine have mapped a critical component of the Nipah virus, a highly lethal bat-borne pathogen that has caused outbreaks...
Researchers have developed a groundbreaking method to rapidly identify infectious and vaccine-resistant variants of viruses and bacteria, including those causing influenza, COVID-19, whooping cough, and tuberculosis...
The latest omicron subvariants carry specific mutations that may allow the SARS-CoV-2 virus to be better at evading immune protection Over the last year, a whole different family of COVID-19 variants has emerged...
The U.S. is currently grappling with another outbreak of West Nile virus (WNV), a mosquito-borne illness that has become the leading cause of epidemic encephalitis in the country. The Centers for Disease Control and...
Researchers from the University of Liverpool’s Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA...
An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines. The global consortium will lay the crucial groundwork needed to...
No increased risks for babies, and for some serious neonatal complications lower risks. This is the result of the largest study to date on the safety of newborn babies whose mothers were vaccinated against COVID-19...
Artificial intelligence is a new addition to the infectious disease researcher’s toolbox. Yet in merely half a decade, AI has accelerated progress on some of the most urgent issues in medical science and public health...
An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, and thus might serve one day as a general preventative...
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced. The vaccine showed success in stimulating production of rare immune cells...